Stimulator of interferon genes (STING) has emerged as a key signaling receptor that 25 induces proinflammatory cytokines, and small molecule STING agonists are being 26 developed as anticancer and antiviral agents. Here we report a strategy of delivering a 27 STING agonist from within live BCG. We generated a recombinant BCG (BCG-disA-OE) 28 that overexpresses the endogenous mycobacterial diadenylate cyclase gene and 29 releases high levels of the STING agonist c-di-AMP. In macrophages BCG-disA-OE 30 elicited statistically significantly stronger TNF-α, IL-6, IL-1β, IRF3, and IFN-β levels than 31 BCG-WT. In a 24-week guinea pig vaccination-Mtb challenge model, BCG-disA-OE 32 reduced lung weights, pathology scores, and Mtb CFU counts in lungs by 28% (p<0.05), 33 34%, and 2.0 log10 CFU units (p < 0.5) compared with BCG-WT, respectively. 34
INTRODUCTION
enhance systemic immunity, however, may be limited by rapid systemic clearance and 62 by the fact that as negatively charged molecules, CDNs do not effectively cross cell 63 strains showed a significant 2-fold induction of IRF3 as compared to that observed with 107 the wild-type parental strain BCG-Pasteur-WT (Supplementary Figure 2a) . These 108 preliminary results suggested that heightened levels of c-di-AMP release from 109 BCG-disA-OE produced significant activation of the STING/IRF3 axis, an observation 110 similar to our earlier findings with Mtb-disA-OE [12] . 111
Next we infected primary murine BMDMs with BCG-disA-OE and BCG-WT and 112
quantified Ifnb gene expression using qPCR. BCG-disA-OE-infected macrophages 113
showed a 2-fold induction of Ifnb (p < 0.005, Supplementary Fig 2b) during an early 114 temporal window. The notion that CDNs such as c-di-AMP can induce STING-dependent, 115 but c-GAS independent induction of type I IFN responses (even in absence of 116 extracellular DNA) was validated earlier, and these results were in accordance with our 117 previous findings with recombinant M.tb overexpressing disA [12] . Previous studies 118
suggest that viral infection of non-phagocytic cells lead to cytosolic penetration by leaking 119
CDNs thus resulting into IFNβ production [18] . Since BCG lacks a functional Esx-1 120 secretion system required to release bacterial DNA, these results further reinforce the 121 idea that phagosomes harboring mycobacteria are rather dynamic leaky structures or 122 really do not require Esx-1 for membrane disruption [19] . Our data indicate that bacterial-123 derived c-di-AMP is detected in the macrophage cytosol and leads to STING-dependent 124 IFN-β synthesis. Increased levels of type I IFNs in macrophages in response to increased 125 c-di-AMP production in genetically modified BCG was the first step towards generation of 126 a vaccine strain with an increased antigenic repertoire and ability to stimulate STING. 127
Although, the binding affinity of c-di-AMP for STING is weaker than that for 131 cGAMP, ligation of c-di-AMP with STING appears sufficient to induce co-activation of 132 transcription factors other than IRF-3 and, hence induction of pro-inflammatory cytokines 133 [20, 21] . Identification of another bona-fide physiological sensor for c-di-AMP, an 134 endoplasmic adaptor, ERAdP, that binds to c-di-AMP with higher affinity, suggests 135
ERAdP-dependent initiation of activation of NF-KB signaling in innate immune cells during 136 bacterial infection [20] . We previously showed that disA-OE strains of M.tb induce a 137 strong pro-inflammatory cytokines, such as TNF-α, IL-6 and IL-1β, suggesting 138 macrophage activation and a complex link between c-di-AMP-based STING activation 139 and induction of pro-inflammatory cytokines and other interferon stimulated genes (ISGs) 140
[12]. Bone marrow-derived primary murine macrophages infected with BCG-disA-OE 141 showed significant increased levels of TNF-α, IL-6 and IL-1β in culture supernatants as 142 compared to uninfected or BCG-WT-infected controls (Figure 1) . These results reveal a 143 robust macrophage activation phenotype in response to c-di-AMP overproducing BCG 144 with increased levels of M1 or Th1 cytokines (TNF-α, IL-1β and IL-6) that is more 145 pronounced than that seen with BCG-WT. 146 147 CDN-adjuvanted recombinant BCG offers better protection against virulent M.tb 148 challenge in guinea pigs 149
Our in vitro studies accessing macrophage response due to increased levels of 150 c-di-AMP encouraged us to test the vaccine potential of BCG-disA-OE in the guinea pigpigs were vaccinated intradermally with 0.1 ml of PBS (sham vaccination), 10 5 CFU of 153 BCG-disA-OE or BCG-WT and held for six weeks before challenge with aerosol 154 challenge with 10 2 CFU of M. tuberculosis H37Rv. As described in the Methods, lungs 155 from one set of infected animals were obtained on day 1 after challenge to confirmed 156 this implantation dose of M. tuberculosis (Supplementary Figure 4) . Separate groups 157 of infected animals were euthanized 14 and 18 weeks post-challenge to determine the 158 protective efficacies of BCG-disA-OE and BCG-WT by organ weight, gross pathology, 159 and bacterial loads in lungs and spleen. 160 At 14-week post-challenge, both BCG-WT and BCG-disA-OE vaccinated animals 161 showed significantly lower lung weight, gross pathology scores, and the bacillary loads 162 in the lungs, relative to saline-treated controls (Figure 2A and 2B) . Vaccination with 163 BCG-disA-OE resulted in the highest reduction in lung gross pathology score, which 164 was even more pronounced at 18-week post-challenge ( Figure 3A and 3B) . While the 165 impact of BCG-disA-OE vaccination on lung CFU counts was modest at the 14 week 166 time point, by the 18 week time point lung CFU counts in the BCG-disA-OE vaccinated 167 guinea pigs were 2.0 log10 units lower than in animals vaccinated with BCG-WT. In 168 fact, two out of six guinea pigs in BCG-disA-OE group had lung CFU counts below the 169 limit of detection which is ~3-5 bacilli. 170
Additionally, vaccination with BCG-disA-OE effectively controlled the 171 hematogenous spread of M.tb to the spleen as evident from significant reduction in 172 spleen weights, spleen pathology scores, and spleen bacterial burdens when compared 173 with the sham-immunized animals at both 14 and 18 week post-infectionwere comparable between animals vaccinated with wild-type and disA overexpressing 176 BCG at 14-weeks post-challenge (Supplementary Fig 5) , by 18 weeks after challenge 177 significantly spleen lower pathology scores was observed in the latter group (Figure 4) . 178
In addition, there was a trend towards lower spleen CFU in animals vaccinated with 179 disA overexpressing strain compared to BCG, especially when examined at 18-weeks 180 post-challenge (Supplementary Figure 4) . Indeed, at 18 weeks post-challenge, three 181 out of six guinea pigs in BCG-disA-OE group had spleen CFU below the limits of 182 detection. These findings clearly indicate that administration of BCG-disA-OE effectively 183 controlled M.tb replication in the lungs and its dissemination to the spleen. 
BCG. 208
Complex genomic rearrangements in BCG strains are one of the major 209 contributors of immunological and phenotypic differences that in turn contribute to the 210 variability in the degree of protection offered by BCG [16, 25] . A global resurgence of 211 MDR-TB, HIV-TB co-infection has heightened the need for an improved TB vaccine that 212 provides better protection than that of BCG. Additionally, new vaccines must be safe 213 enough to be used in immunocompromised HIV-TB co-infected individuals. Rational 214 modification of live BCG to increase its antigenic repertoire, and with a prior knowledge 215 of attenuation factors and immunity is critically needed [14, 17] . While our study did not 216 directly assess the virulence of BCG-disA-OE to that of BCG-WT, based on the finding 217 that Mtb-disA-OE showed a median time to death in BALB-c mice of 321.5 days compared 218 to 150.5 days for Mtb-WT following an aerosol infection of 3.5 log10 CFU [12], we 219
anticipate that BCG-disA-OE is a weaker pathogen than BCG-WT. Real Time PCR System (Applied Biosystems, USA). Amplification of sigH and mouse 296 beta actin was used as internal controls for BCG and mouse BMDMs respectively. Melt 297 curve analyses confirmed formation of desired and specific PCR product. Experiments 298 were performed in triplicate using three independent biological samples and results were 299 analyzed and presented using 2 -∆∆CT method. Details of NCBI gene identifiers and primer 300 sequences are mentioned (Supplementary Table 2) . 301
Macrophage infection, IRF3 activation assay and cytokine ELISAs: Infection assays 302
were performed in resting mouse BMDMs in 24 well plates in triplicates. Briefly, early log-303 phase cultures of BCG strains were washed, diluted appropriately to pre-defined 304 concentrations using macrophage infection media (DMEM with 10% FBS) and deposited 305 on the monolayer of cells at a precalibrated MOI (1:20) . Infection was allowed continue 306 for 5 h, following which uninfected extracellular bacilli were removed by repeated washing 307 using Dulbecco's PBS (DPBS). This time point was considered 0 h and the cells were 308 incubated for desired number of hours till the end points were met. To access accurate 309 bacterial counts of infection and internalized bacterial numbers, serial dilutions of thebacterial suspension and 0.025% SDS lysed macrophage were plated on 7H9 plates. 311 RAW-Blue ISG (InvivoGen) reporter cells, derived from the murine RAW 264.7 312 macrophage cell line by stably integrating an interferon regulatory factor (IRF)-inducible 313 secreted embryonic alkaline phosphatase (SEAP) reporter construct were used for IRF 314 activation assay. The cells were infected with wild-type and BCG-disA-OE strains. Cells 315 were incubated for 18 h in fresh macrophage infection media (DMEM with 10% FBS), and 316 culture supernatants were harvested for determination of IRF activation by a SEAP 317 colorimetric assay using QUANTI-Blue reagent (InvivoGen). Following macrophage 318 infection, culture supernatants were isolated, filtered and immediately frozen at -80 for 319 cytokine quantification. Mouse DuoSet ELISA kits for TNF (DY410), IL-6 (DY206-05) and 320
IL1β (DY201-05) were used for cytokine quantification. The absolute concentrations were 321 determined by referring to a standard curve and expressed as pg/mL. For quantification 322 experiments were performed in triplicates. 323
Guinea pig immunization and determination of protective efficacy: To test the 324
prophylactic potential of BCG-disA-OE as a vaccine candidate, guinea pigs (n=12 per 325 group) were immunized intradermally using 10 5 cfu/100 µl of wild-type parental BCG 326
Pasteur or BCG-disA-OE strains. Guinea pigs were sham immunized with saline. Animals 327 were challenged with ~100 cfu of M.tb H37Rv strain by the aerosol route 6 weeks 328 (Supplementary Figure 1) after primary immunization. Lungs from one set of infected 329 animals were harvested, and homogenates were plated on day 1 after to check for 330 established implantation. Infected animals from each group were euthanized 14 and 18 331 weeks later to determine the protective efficacy of the BCG-disA-OE. Gross-pathological 332 features and bacillary burden in lungs and spleen of sham and BCG-immunized guinea Figure 3 shows the details of experimental plan and different animal groups used in the 335 study and Supplementary Table 1 depicts the bacterial strains and plasmid used in the 336
study. 337
Statistical analyses: Fold-expression (qRT-PCR and ELISA) were represented as mean 338 value ± standard error mean (SEM). Differences between individual test groups were 339 analyzed using by applying unpaired Student's t-test. All statistics was performed using 340
GraphPad Prism Version 5.01. P values < 0.05 were considered statistically significant. 341
342
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The authors thank Dr. Geetha Srikrishna for help with manuscript writing and editing. This BCG-disA-OE strains at an MOI of 1:20 for 5 hours to establish the infection. Uninfected 511 bacteria were washed using ice-cold DPBS and cells were subsequently incubated for 512 another 6 hours. Expression levels of mRNA was measured using a SYBR green-based 513 quantitative real-time PCR. Basal level of transcript (mRNA) in untreated macrophages 514 was used for data normalization and hence to access relative expression. -actin was 515 used as an internal control. Data analysis was performed using 2 −∆∆CT method. The 516 graphical points represent mean of 3 independent experiments ± standard error mean 517 (SEM). Student's t test (***P < 0.0005, **P<0.001). MOI (multiplicity of infection). 
